CLINICAL INNOVATION ApS: Financial statements 2014
CVR: 29924880
Source: annual report 2014, Danish Business Authority
01/10/2013 – 30/09/2014
CLINICAL INNOVATION ApS (CVR 29924880) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 2,821,058 and a net result of DKK 483,057 compared with DKK 544,865 the year before. That is a decrease of 6.6% compared with the year before. Equity in the 2014 report amounted to DKK 2,877,883. The solvency ratio was 49.6%.
- Gross Profit
- DKK 2,821,058
- Profit/Loss
- DKK 483,057
- Equity
- DKK 2,877,883
- Total Assets
- DKK 5,803,618
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 2.8 mio. | 483 t. | 2.9 mio. | - |
| 2013 | - | 3 mio. | 545 t. | 2.6 mio. | - |
| 2012 | - | 2.4 mio. | 550 t. | 2.4 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
CLINICAL INNOVATION ApS has published its annual report for 2013. Gross profit came to DKK 3,021,992, and the net result was DKK 544,865.
About CLINICAL INNOVATION ApS
CLINICAL INNOVATION ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Claus Michael Dinesen. The board consists of Ole Hedemann (chair), Claus Michael Dinesen, Magnus Oliver Lorentzen Dinesen and Marc Phillip Gall Schultz Lorentzen. The company is owned by PIA & CLAUS DINESEN HOLDING ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 2,775,826 and a net result of DKK 413,835 compared with DKK 95,746 the year before. Equity in the 2025 report amounted to DKK 3,821,950.